Most Recent
Mayne Pharma has launched a bid for a $13.6 million gross sum costs order against US drug maker Cosette, after winning one of numerous legal challenges over the termination of a $672 million merger agreement.
Aged care provider Bupa can't challenge the dismissal of its bid for a quick win in a class action over the standard of care at its facilities, despite a court noting the case has "some curiosities".
Bayer and Teva have lost their challenge to Indian drug maker Cipla’s extension of its patent for an allergy medication, with IP Australia finding a failure to pay renewal fees on time was due to a genuine error.
A Melbourne gynaecologist faces a possible class action by women who claim they underwent unnecessary endometriosis surgeries.
ASX-listed Mayne Pharma has taken US drug maker Cosette to court seeking "substantial damages" over the termination of their $672 million merger.
AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.
Private hospital operator Ramsay Health has won swift ACCC approval for its $251 million acquisition of Canberra hospital National Capital Private Hospital from Healthscope, with the regulator completing its review in three weeks.
One of the firms that secured a record $230 million settlement in a class action on behalf of NSW doctors is still on the case, firing off a class action against Sydney's St Vincent's Hospital for allegedly underpaying junior doctors.
A tribunal has found millionaire property mogul and cosmetic surgeon Jerry Schwartz guilty of professional misconduct, after finding he inappropriately treated himself and four family members and flouted registration conditions by administering fentanyl to patients.
AstraZeneca has sued Pharmacor over its plans to list a generic version of blockbuster diabetes drug Forxiga on the PBS, but the drug maker will have to defend the validity of the patent, which was struck down by a UK court last year.